메뉴 건너뛰기




Volumn 18, Issue 10, 2008, Pages 903-910

Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor γ agonists

Author keywords

Calu 6; Cynomolgus; Diabetes; Epithelial sodium channel (EnaC); Fluid retention; Glitazar; Pharmacogenetics; Polymorphism; Renin angiotensin aldosterone system; Single nucleotide polymorphism; Thiazolidinedione

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BMS 251208; BMS 264953; BMS 350336; BMS 375843; BMS 426707; BMS 576980; BMS 577155; BMS 686393; BMS 686394; BMS 697199; ENDOTHELIN 1; FARGLITAZAR; MURAGLITAZAR; PELIGLITAZAR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PLACEBO; PRAVASTATIN; RAGAGLITAZAR; RENIN; ROSIGLITAZONE; TESAGLITAZAR; UNCLASSIFIED DRUG;

EID: 53549106595     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32830a6ea0     Document Type: Article
Times cited : (14)

References (25)
  • 1
    • 0842263981 scopus 로고    scopus 로고
    • The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity
    • Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004; 153 (1):S43-S50.
    • (2004) Diabetes , vol.153 , Issue.1
    • Ferre, P.1
  • 2
    • 33644645013 scopus 로고    scopus 로고
    • PPAR delta: A dagger in the heart of the metabolic syndrome
    • Barish GD, Narkar VA, Evans RM. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 2006; 116:590-597.
    • (2006) J Clin Invest , vol.116 , pp. 590-597
    • Barish, G.D.1    Narkar, V.A.2    Evans, R.M.3
  • 3
    • 3042634455 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo: A study using the novel PPAR alpha/gamma agonist tesaglitazar
    • Hegarty BD, Furler SM, Oakes ND, Kraegen EW, Cooney GJ. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo: a study using the novel PPAR alpha/gamma agonist tesaglitazar. Endocrinology 2004; 145:3158-3164.
    • (2004) Endocrinology , vol.145 , pp. 3158-3164
    • Hegarty, B.D.1    Furler, S.M.2    Oakes, N.D.3    Kraegen, E.W.4    Cooney, G.J.5
  • 4
    • 33644783769 scopus 로고    scopus 로고
    • Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice
    • Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, et al. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice. Diabetes 2006; 55:240-248.
    • (2006) Diabetes , vol.55 , pp. 240-248
    • Harrity, T.1    Farrelly, D.2    Tieman, A.3    Chu, C.4    Kunselman, L.5    Gu, L.6
  • 5
    • 33745957332 scopus 로고    scopus 로고
    • Improvement of glycemic control, trigtycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazonecomparative study
    • Kendall DM, Rubin CJ, Mohideen P, Ledeine JM, Bolder R, Gross J, et al. Improvement of glycemic control, trigtycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a double-blind, randomized, pioglitazonecomparative study. Diabetes Care 2006; 29:1016-1023.
    • (2006) Diabetes Care , vol.29 , pp. 1016-1023
    • Kendall, D.M.1    Rubin, C.J.2    Mohideen, P.3    Ledeine, J.M.4    Bolder, R.5    Gross, J.6
  • 6
    • 0346219290 scopus 로고    scopus 로고
    • Considerations for management of fluid dynamic issues associated with thiazolidinediones
    • Hollenberg NK. Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med 2003; 115 (Suppl 8A): 111S-115S.
    • (2003) Am J Med , vol.115 , Issue.SUPPL. 8A
    • Hollenberg, N.K.1
  • 7
    • 0344304678 scopus 로고    scopus 로고
    • Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association
    • Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation 2003; 108:2941-2948.
    • (2003) Circulation , vol.108 , pp. 2941-2948
    • Nesto, R.W.1    Bell, D.2    Bonow, R.O.3    Fonseca, V.4    Grundy, S.M.5    Horton, E.S.6
  • 8
    • 0041778253 scopus 로고    scopus 로고
    • Thiazolidinedione-associated congestive heart failure and pulmonary edema
    • Kermani A, Garg A. Thiazolidinedione-associated congestive heart failure and pulmonary edema. Mayo din Proc 2003; 78:1088-1091.
    • (2003) Mayo din Proc , vol.78 , pp. 1088-1091
    • Kermani, A.1    Garg, A.2
  • 9
    • 21544479710 scopus 로고    scopus 로고
    • Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention
    • Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci U S A 2005; 102:9406-9411.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 9406-9411
    • Zhang, H.1    Zhang, A.2    Kohan, D.E.3    Nelson, R.D.4    Gonzalez, F.J.5    Yang, T.6
  • 10
    • 23844472901 scopus 로고    scopus 로고
    • Thiazolidinediones expand body fluid volume through PPAR gamma stimulation of ENaC-mediated renal salt absorption
    • Guan Y, Hao C. Cha DR, Rao R, Lu W, Kohan DE, et al. Thiazolidinediones expand body fluid volume through PPAR gamma stimulation of ENaC-mediated renal salt absorption. Nat Med 2005; 11:861-866.
    • (2005) Nat Med , vol.11 , pp. 861-866
    • Guan, Y.1    Hao, C.2    Cha, D.R.3    Rao, R.4    Lu, W.5    Kohan, D.E.6
  • 12
    • 21244494825 scopus 로고    scopus 로고
    • Strong association of a renin intronic dimorphism with essential hypertension
    • Ahmad U, Saleheen D, Bokhari A, Frossard PM. Strong association of a renin intronic dimorphism with essential hypertension. Hypertens Res 2005; 28:339-344.
    • (2005) Hypertens Res , vol.28 , pp. 339-344
    • Ahmad, U.1    Saleheen, D.2    Bokhari, A.3    Frossard, P.M.4
  • 13
    • 0032895749 scopus 로고    scopus 로고
    • The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people
    • Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJ, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999; 33:1169-1174.
    • (1999) Hypertension , vol.33 , pp. 1169-1174
    • Tiret, L.1    Poirier, O.2    Hallet, V.3    McDonagh, T.A.4    Morrison, C.5    McMurray, J.J.6
  • 14
    • 0033617342 scopus 로고    scopus 로고
    • A gain-of-function polymorphism in a G-protem coupling domain of the human betaladrenergrc receptor
    • Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protem coupling domain of the human betaladrenergrc receptor. J Biol Chem 1999; 274:12670-12674.
    • (1999) J Biol Chem , vol.274 , pp. 12670-12674
    • Mason, D.A.1    Moore, J.D.2    Green, S.A.3    Liggett, S.B.4
  • 15
    • 0037385575 scopus 로고    scopus 로고
    • A common beta 1-adrenergic receptor polymorphism (Arg389Gry) affects blood pressure response to beta-blockade
    • Sofowora GG, Dishy V, Muazkat M, Xie HG, Kim RB, Harris PA, et al. A common beta 1-adrenergic receptor polymorphism (Arg389Gry) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 2003; 73:366-371.
    • (2003) Clin Pharmacol Ther , vol.73 , pp. 366-371
    • Sofowora, G.G.1    Dishy, V.2    Muazkat, M.3    Xie, H.G.4    Kim, R.B.5    Harris, P.A.6
  • 17
    • 0033520304 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor activators inhibit thrombininduced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway
    • Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, et al. Peroxisome proliferator-activated receptor activators inhibit thrombininduced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 1999; 85: 394-402.
    • (1999) Circ Res , vol.85 , pp. 394-402
    • Delerive, P.1    Martin-Nizard, F.2    Chinetti, G.3    Trottein, F.4    Fruchart, J.C.5    Najib, J.6
  • 18
  • 19
    • 0028900531 scopus 로고
    • Endogenous human renin expression and promoter activity in Calu-6, a pulmonary carcinoma cell line
    • Lang JA, Yang G, Kern JA, Sigmund CD. Endogenous human renin expression and promoter activity in Calu-6, a pulmonary carcinoma cell line. Hypertension 1995; 25:704-710.
    • (1995) Hypertension , vol.25 , pp. 704-710
    • Lang, J.A.1    Yang, G.2    Kern, J.A.3    Sigmund, C.D.4
  • 20
    • 35848935619 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma is involved in the control of renin gene expression
    • Todorov VT, Desch M, Schmitt-Nilson N, Todorova A, Kurtz A. Peroxisome proliferator-activated receptor-gamma is involved in the control of renin gene expression. Hypertension 2007; 50:939-944.
    • (2007) Hypertension , vol.50 , pp. 939-944
    • Todorov, V.T.1    Desch, M.2    Schmitt-Nilson, N.3    Todorova, A.4    Kurtz, A.5
  • 22
    • 0012182716 scopus 로고
    • Izzo J, Black HR, editors, Philadelphia: Lippincott Williams & Williams;
    • Izzo J, Black HR, editors. Hypertension primer. Philadelphia: Lippincott Williams & Williams; 1993.
    • (1993) Hypertension primer
  • 25
    • 1642302410 scopus 로고    scopus 로고
    • Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men
    • Zanchi A, Chiolero A, Maillard M, Nussberger J, Brunner HR, Burner M. Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men. J Clin Endocrinol Metab 2004; 89:1140-1145.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 1140-1145
    • Zanchi, A.1    Chiolero, A.2    Maillard, M.3    Nussberger, J.4    Brunner, H.R.5    Burner, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.